Member Info for Yorkshirepragma

https://www.fiercebiotech.com/special-report/top-15-biopharma-licensing-deals-2020

I’ll just add as a retired ‘pharma bod’ . AB’s on the radar of many. My old pals who follow the game are v positive.
….not. Punt anymore..
Gla

….Nothing wrong with good solid turnover/ margin co purchase today…great move.
….Upcoming entry to multi £bn product with Dox results imminent, and more relevant “kindness benefits” to patients in a novel chemo.
…broad range Affimer capabilities recognised by many ,as per jvs etc
Blinder…
£2bn+/- market cap on results and r3cognition etc …or I’ll go to sea.
GLA

https://www.biopharmadive.com/news/biotech-pharma-deals-merger-acquisitions-tracker/604262/

On success £2bn +/- market cap. Ie £8.
With interest …++

There appear no aberrations in the med community on the evaluation .
All sound

States promotes “Socially responsible partnerships” whilst shorting a cancer treatment development co…..what hypocrisy.
Jupiter …shame.

Up significantly on Oncology news. Bodes well…

What a cheery post…and potentially accurate on estimates. Word is M&A interest is on the up, with cheaper £/$ etc. On results £2bn +/-.
Gla

And TW lives on a dilapidated ‘farm’ so where in N Wales. . Need we say more

On results (+ve) m.cap £2bn+/-. Forget the rest.
After that…better.
Forget the nonsense
PS there IS interest already..see the various evidence and use cs.
GLA

Sealgen analogy ,away away ,but very valid .

https://newmarket-strategy.com

Novartis 3/1 :AZ 5/2 : Takeda 3/2 : Sanofi 2/1 etc etc

Reflection, YES this mod. to Doxo ( as it’s affectionately known in the business),will hopefully lead to a further extension (and with greater efficacy) of this superb life saving drug.
Market …enorme’

Watching , well said. Have a good bank holiday.

Success next month will bring out the eagles. It will not take long to crest interest .
My view ... anytime shortly( ex Pharma)
AZ ...5/2....
GLA

Tight ship = potential M&A

https://www.fiercebiotech.com/biotech/teneotwo-put-play-amgen-lands-100m-astrazeneca-buyout-back-blood-cancer-bispecific

See AZN intentions vis cancer treatments GF.
GLA

It would be excellent to see Av testing’ in train’ again, but fear John Bell / Porton Down mess up has put the kaibosh on options gf.
GLA